Monograph

J01DB05 - Cefadroxil

Propably not porphyrinogenic

Rationale

Not metabolised. No data pointing to CYP interaction. Conflicting references.

Chemical description

Perorally used cephalosporin (500 mg x 2) antibiotic used in uncomplicated urinary tract infections, skin and soft tissue infections and in pharyngotonsillitis where penicillin V has shown to be without effect. Only about 2 % is metabolized by decarbamylation, the drug thus mainly excreted in unchanged form by the kidneys. No data pointing to CYP-affinity. South African list: use with caution . French list: unsafe. Andersson:used occasionally without side effects.Said by one patient, however, to have triggered symtoms.

IPNet drug reports

Uneventful use reported in 2 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes J01D / J01DB or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Belgium

Cefadroxil · Cefadroxil Sandoz 500 mg gél. · Duracef · Duracef 250 mg/5 ml susp. buv. (pdr.) · Duracef 500 mg/5 ml susp. buv. (pdr.)

United Kingdom

Baxan · Baxan 125mg/5ml oral suspension · Baxan 250mg/5ml oral suspension · Baxan 500mg capsules · Baxan 500mg/5ml oral suspension · Cefadroxil · Cefadroxil 500mg capsules

Poland

Duracef · Valdocef

Luxembourg

DURACEF

Latvia

Biodroxil · Duracef

Serbia

VALDOCEF · VALDOCEF®

Acute Porphyria Drug Database

Monograph